| Clinical characteristics | Mean age (yr) | 60.7±12.9 (27–84) |
| Sex | |
| Male | 91 (63.6) |
| Female | 52 (36.4) |
| Tumor location | |
| Antrum | 74 (51.7) |
| Corpus | 69 (48.3) |
| Median overall survival (mo) | 45 (0–155) |
| Died patient | 66 (46.2) |
| Cause of death | |
| Gastric cancer | 47 (32.9) |
| Hepatocellular carcinoma | 5 (3.5) |
| Liver cirrhosis | 2 (1.4) |
| Cardiologic disease | 2 (1.4) |
| End stage renal disease | 1 (0.7) |
| Pneumonia | 1 (0.7) |
| Another cancer | 1 (0.7) |
| Could not identify cause | 7 (4.9) |
| Purpose of operation | |
| Curative | 117 (81.8) |
| Palliative | 26 (18.2) |
| Recurrent patient | 21 (14.7) |
| CEA (n=130) | |
| ≤5 | 115 (88.5) |
| >5 | 15 (11.5) |
| CA19-9 (n=124) | |
| ≤27 | 104 (83.9) |
| >27 | 20 (16.1) |
| Pathologic characteristics | Early gastric cancer | 58 (40.6) |
| Advanced gastric cancer | 85 (59.4) |
| WHO classification | |
| Tubular adenocarcinoma | 90 (62.9) |
| Well differentiated | 18 (12.6) |
| Moderate differentiated | 34 (23.8) |
| Poorly differentiated | 38 (26.6) |
| Papillary adenocarcinoma | 1 (0.7) |
| Mucinous adenocarcinoma | 9 (6.3) |
| Signet ring cell carcinoma | 43 (30.1) |
| Lauren classification | |
| Intestinal | 68 (47.6) |
| Diffuse & mixed | 75 (52.4) |
| Vascular invasion (n=140) | |
| No | 108 (77.1) |
| Yes | 32 (22.9) |
| Lymphatic invasion | |
| No | 80 (55.9) |
| Yes | 63 (44.1) |
| Perineural invasion (n=140) | |
| No | 99 (70.7) |
| Yes | 41 (29.3) |
| T stage | |
| Tis, T1 | 55 (38.5) |
| T2, T3, T4 | 88 (61.5) |
| N stage | |
| N0 | 66 (46.2) |
| N1, N2, N3 | 77 (53.8) |
| M stage | |
| M0 | 131 (91.6) |
| M1 | 12 (8.4) |